Nov 18, 2015 7:00 am EST Heat Biologics Selected as One of Informa's 2015 Top 10 Immuno-Oncology Companies to Watch
Nov 06, 2015 7:00 am EST Heat Biologics Reports HS-410 Phase 1 Bladder Cancer Trial Results at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 03, 2015 8:00 am EST Results of Heat Biologics' HS-410 Phase 1 Safety Trial in Non-Muscle Invasive Bladder Cancer to be Presented at SITC Annual Meeting
Oct 14, 2015 7:00 am EDT Heat Biologics Expands Scientific and Clinical Advisory Board With Appointments of Drs. Holbrook Kohrt and Kapil Dhingra
Oct 08, 2015 7:00 am EDT Heat Biologics Completes Patient Enrollment for Randomized Arms of Its Phase 2 HS-410 Bladder Cancer Trial
Oct 07, 2015 7:00 am EDT Heat Biologics to Participate in the Annual Prostate Cancer Foundation Scientific Retreat
Sep 16, 2015 9:01 am EDT Heat Biologics to Present New Data on Its ComPACT Platform at the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference
Sep 02, 2015 8:00 am EDT Heat Biologics, Inc. to Present at the 17th Annual Global Investment Conference